Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma.
Yang P, Kulig K, Boland JM, Erickson-Johnson MR, Oliveira AM, Wampfler J, Jatoi A, Deschamps C, Marks R, Fortner C, Stoddard S, Nichols F, Molina J, Aubry MC, Tang H, Yi ES.
Yang P, et al.
J Thorac Oncol. 2012 Jan;7(1):90-7. doi: 10.1097/JTO.0b013e31823c5c32.
J Thorac Oncol. 2012.
PMID: 22134072
Free PMC article.